BR0311722A - Compostos de ciclodextrina com amÈnia quaternizado - Google Patents

Compostos de ciclodextrina com amÈnia quaternizado

Info

Publication number
BR0311722A
BR0311722A BR0311722-7A BR0311722A BR0311722A BR 0311722 A BR0311722 A BR 0311722A BR 0311722 A BR0311722 A BR 0311722A BR 0311722 A BR0311722 A BR 0311722A
Authority
BR
Brazil
Prior art keywords
cyclodextrin
compound
alkylene
group selected
cyclodextrin compounds
Prior art date
Application number
BR0311722-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Georg Ludwig Kis
Christian Schoch
Jozsef Szejtli
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR0311722A publication Critical patent/BR0311722A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/724Cyclodextrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BR0311722-7A 2002-06-13 2003-06-12 Compostos de ciclodextrina com amÈnia quaternizado BR0311722A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02013074 2002-06-13
EP02028554 2002-12-20
PCT/EP2003/006192 WO2003105867A1 (en) 2002-06-13 2003-06-12 Quaternised ammonium cyclodextrin compounds

Publications (1)

Publication Number Publication Date
BR0311722A true BR0311722A (pt) 2005-03-01

Family

ID=29737927

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0311722-7A BR0311722A (pt) 2002-06-13 2003-06-12 Compostos de ciclodextrina com amÈnia quaternizado

Country Status (15)

Country Link
US (4) US20050222085A1 (https=)
EP (1) EP1515729B1 (https=)
JP (2) JP4773721B2 (https=)
CN (1) CN100589809C (https=)
AT (1) ATE386532T1 (https=)
AU (1) AU2003276957A1 (https=)
BR (1) BR0311722A (https=)
CA (1) CA2487332C (https=)
CY (1) CY1108099T1 (https=)
DE (1) DE60319221T2 (https=)
DK (1) DK1515729T3 (https=)
ES (1) ES2301807T3 (https=)
PT (1) PT1515729E (https=)
SI (1) SI1515729T1 (https=)
WO (1) WO2003105867A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100678824B1 (ko) * 2005-02-04 2007-02-05 한미약품 주식회사 용해성이 증가된 무정형 타크로리무스 고체분산체 및 이를포함하는 약제학적 조성물
CN101410123A (zh) 2006-03-28 2009-04-15 杰佛林制药公司 低剂量的双氯芬酸和β-环糊精的制剂
WO2008120249A1 (en) * 2007-03-30 2008-10-09 Sifi S.P.A. Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
CN101757621B (zh) * 2008-11-28 2012-07-04 天津金耀集团有限公司 一种眼部抗炎的环糊精包合药物组合物
US9642920B2 (en) * 2009-06-03 2017-05-09 Case Western Reserve University Therapeutic agent delivery system and method
CN102276761A (zh) * 2010-06-11 2011-12-14 南京理工大学 单取代铵基正电型-β-环糊精及其制备方法
GB201114459D0 (en) * 2011-08-22 2011-10-05 Isis Innovation Anti-bacterial compounds
CN103497275B (zh) * 2013-08-09 2015-12-23 华北电力大学(保定) 一种抗菌、抗病毒胍盐星形聚合物及其制备方法和应用
CZ307458B6 (cs) * 2014-11-25 2018-09-12 Spur A.S. Vícevrstvý kryt rány s aktivní vrstvou a způsob jeho výroby
US20170360040A1 (en) * 2014-12-02 2017-12-21 B.G. Negev Technologies And Applications Ltd., At Ben-Gurion University Modified polysaccharides for use as anti-microbial agents
CN109487588B (zh) * 2018-11-19 2021-04-20 绍兴永通印花有限公司 一种印花用涤纶织物处理液及其使用方法
CN113056516B (zh) 2019-02-14 2022-05-13 赛克洛珀股份有限公司 带有电荷的环糊精聚合物材料以及其制造和使用方法
CN109836512A (zh) * 2019-03-04 2019-06-04 西南石油大学 一种新型β-CD双子表面活性剂为稠化剂的清洁压裂液
CN112386710A (zh) * 2020-12-09 2021-02-23 星拜(苏州)生物科技有限公司 一种利用包埋技术改善紫檀芪水溶性的方法
CN116987213B (zh) * 2022-04-26 2025-09-09 中国石油化工股份有限公司 一种具有表面活性剂功能的化合物、一种表面活性剂及其制备方法
AU2024207157A1 (en) 2023-01-12 2025-06-26 Cyclopure, Inc. Regeneration of polymeric cyclodextrin adsorbents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3453257A (en) * 1967-02-13 1969-07-01 Corn Products Co Cyclodextrin with cationic properties
JPS58210901A (ja) * 1982-06-01 1983-12-08 Kao Corp シクロデキストリン誘導体およびその製造方法
IT1229133B (it) * 1989-03-09 1991-07-22 Farmhispania Sali ammonici di policiclodestrine per l'impiego come agenti ipocolesterolemizzanti
JPH0481401A (ja) * 1990-07-24 1992-03-16 Toppan Printing Co Ltd シクロデキストリン誘導体
CA2063454A1 (en) * 1990-05-21 1991-11-22 Masanobu Yoshinaga Cyclodextrin derivatives
JPH0665307A (ja) * 1992-06-17 1994-03-08 Sankyo Co Ltd シクロデキストリン誘導体
US5891913A (en) * 1994-10-10 1999-04-06 Novartis Finance Corporation Ophthalmic and aural compositions containing diclofenac potassium
JP3297969B2 (ja) * 1994-12-26 2002-07-02 ライオン株式会社 点眼剤
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
TW434023B (en) * 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
EP1067942A1 (en) * 1998-02-23 2001-01-17 Cyclops, EHF. High-energy cyclodextrin complexes

Also Published As

Publication number Publication date
ATE386532T1 (de) 2008-03-15
SI1515729T1 (sl) 2008-08-31
CA2487332A1 (en) 2003-12-24
CN1658888A (zh) 2005-08-24
ES2301807T3 (es) 2008-07-01
AU2003276957A1 (en) 2003-12-31
PT1515729E (pt) 2008-05-30
JP2011006448A (ja) 2011-01-13
JP2005529175A (ja) 2005-09-29
US20130137657A1 (en) 2013-05-30
CN100589809C (zh) 2010-02-17
WO2003105867A1 (en) 2003-12-24
DK1515729T3 (da) 2008-06-16
DE60319221T2 (de) 2009-03-05
CY1108099T1 (el) 2014-02-12
US20090110734A1 (en) 2009-04-30
DE60319221D1 (de) 2008-04-03
EP1515729A1 (en) 2005-03-23
CA2487332C (en) 2012-05-15
JP4773721B2 (ja) 2011-09-14
EP1515729B1 (en) 2008-02-20
US20050222085A1 (en) 2005-10-06
US20120004158A1 (en) 2012-01-05

Similar Documents

Publication Publication Date Title
BR0311722A (pt) Compostos de ciclodextrina com amÈnia quaternizado
RU2221817C2 (ru) Отвердитель для эпоксидной смолы и композиция эпоксидной смолы
BR0210733A (pt) Derivados de piperidina de utilidade úteis como moduladores da atividade do receptor de quimocina
BR9908007A (pt) Uso de compostos, composto, composição pesticida, e, processos para combater fungos fitopatogênicos e para preparar compostos intermediários
ATE359289T1 (de) Verbindungen zum schutz von hydroxylgruppen und ihre anwendung
BRPI0512060B8 (pt) compostos orgânicos, composições farmacêuticas compreendendo os mesmos, bem como uso e processo de preparação dos referidos compostos
BR0306785A (pt) Deazapurinas e seus usos
DK1019368T3 (da) Acylsulfamoylbenzoesyreamider, nytteplantebeskyttelsesmidler indeholdende disse samt fremgangsmåder til deres fremstilling
BR0006823A (pt) Composição farmacêutica estabilizada, uso de composto de polipeptìdeo cìclico, preparação de injeção e pacote comercial
ATE543515T1 (de) Konjugate von hydroxyalkyl-stärke und einer wirksubstanz, hergestellt durch chemische ligation über thiazolidin
WO2011072853A3 (en) Conditioning composition for hair
BR0308780A (pt) Composto, processo para a preparação e uso do mesmo, método para o tratamento de um sujeito humano ou animal que sofre de, ou que é suscetìvel a, uma condição inflamatória, e, composição farmacêutica
EA199900135A1 (ru) Производные пиразолопиридина и их применение в качестве фармацевтического препарата
ATE409177T1 (de) Synthetische multiple quaternäre ammoniumsalze
BRPI0813809A2 (pt) derivados de 7-alquinil -1,8-naftiridonas, sua preparação e sua aplicação em terapêutica.
BR0011514A (pt) Método, aparelho e composição para inibir a capacidade de mosquitos detectarem um alvo através de emissões olfativas do mesmo num espaço ambiental tridimensional
BR112014009384A2 (pt) uso de antiestáticos em composições de revestimento interno
BR0004534A (pt) Composto, composição farmacêutica, agente contendo um composto, e uso de um composto.
ATE517949T1 (de) Farbstoff und seine anwendung in aufzeichnungsmaterial
BRPI0502897A (pt) compostos corantes
BR9813779A (pt) Novos derivados do taxano
WO2005001423A3 (en) Methods, compositions and devices for performing ionization desorption on silicon derivatives
BRPI0607287A2 (pt) composto nucleosìdico de pirimidina ou seu sal
ATE254146T1 (de) Wässrige beschichtungsmittel auf epoxid/amin- basis und ihre verwendung bei mehrschichtlackierungen
EP1027880A3 (de) Verwendung von quaternären Ammoniumverbindungen als Antitranspirantien

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014.